Nivolumab Injection [Opdivo] Clinical Trials
5 recruitingDrug
Phase 24Phase 11
Showing 1–5 of 5 trials
Recruiting
Phase 2
CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma
Hepatocellular CarcinomaAdvanced Cancer
TaiRx, Inc.95 enrolled5 locationsNCT05257590
Recruiting
Phase 1
Phase I Study VG2025 as a Single Agent and in Combination Therapy With Nivolumab in Subjects With Advanced Malignant Solid Tumors
Solid Tumor
Virogin Biotech Canada Ltd12 enrolled2 locationsNCT05266612
Recruiting
Phase 2
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Hepatocellular CarcinomaIntrahepatic Cholangiocarcinoma
Virogin Biotech Canada Ltd97 enrolled3 locationsNCT05223816
Recruiting
Phase 2
Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma
NeoplasmsAntineoplastic AgentsCarcinoma, Squamous
The First Affiliated Hospital of Guangzhou Medical University25 enrolled1 locationNCT05964101
Recruiting
Phase 2
Melanoma Metastasized to the Brain and Steroids
Malignant Melanoma
Inge Marie Svane80 enrolled3 locationsNCT03563729